Financial Highlights

Arriani Pharmaceuticals S.A. boasts healthy finances, a steadily upward course and an impressively rapid rate of growth. Successful products, strategic partnerships and an insight into the changing needs of the pharmaceutical sector have been key to our positive financial performance. Sound business decisions and efficient management of tangible and intangible resources allow us to advance successfully towards our business and financial goals.

70

Evolution ( x 1000 € )
Nina Potamianou is Co-Founder, Vice President, and Director of Marketing. She holds a PhD in Pharmaceutical Biology.
Site Map

Arriani Pharmaceuticals S.A. is a privately-owned company with exceptionally healthy finances and a steadily upward course since the beginning of its operation. A growth rate exceeding 35% yearly establishes it as one of the fastest-growing pharmaceutical companies in Southeastern Europe.

Sales By Division

% in percentage

25%
2002
2003
2004
2005
2006
2,000
4,000
6,000
8,000
10,000
12,000
0
Financing & Growth
Prescription
OTC & Self Medication
Biotech